Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP)
Sector: Medical
Current Price :
$34.02
52 Week Low
$25.06
52 Week High
$36.05
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
110M
Market Cap:
$3.98B
Avg Volume:
2627412
P/E Ratio:
7.080
PEG Ratio:
1.200
1m
3m
6m
1y
2y
Opinion and Analysis
Endo Health Solutions, Inc: FDA Decision Positive For Opana, But Generics Risks Remain
Apr 19, 2013 09:44 AM |
ENDP
"Defective" Complaint Triggers 30-Month Stay
Mar 14, 2013 01:22 PM |
ENDP
,
MYL
Analysts' Upgrades And Downgrades: AFFY, CMI, ENDP, HNZ, NDSN, SWY, VMW
Feb 25, 2013 10:11 AM |
AFFY
,
CMI
,
ENDP
,
HNZ
,
NDSN
,
SWY
More Articles on ENDP..
Press Releases
Free Research Reports on ENDP, MOBI, MOS and POST Issued by the Paragon Report
May 14, 2013 08:20 AM |
ENDP
,
MOBI
,
MOS
Strategy Behind Our Success, We Get in Early: GLW, ENDP and ANR
May 14, 2013 05:00 AM |
ANR
,
ENDP
,
GLW
Endo Health Solutions Responds to FDA's Denial of OPANA? ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone
May 10, 2013 04:56 PM |
ENDP
More Press Releases on ENDP..
SEC Filings
Form 4 ENDO HEALTH SOLUTIONS For: Mar 08 Filed by: McHugh Julie (10K)
Mar 15, 2013 07:39 PM
Form 4 ENDO HEALTH SOLUTIONS For: Mar 08 Filed by: MANOGUE CAROLINE B (10K)
Mar 15, 2013 07:36 PM
Form 4 ENDO HEALTH SOLUTIONS For: Mar 08 Filed by: Gergel Ivan P. (10K)
Mar 15, 2013 07:35 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ENDP
Compare to S&P
YTD
36.87 %
25.51 %
4 Weeks
16.37 %
16.49 %
12 Weeks
25.92 %
21.69 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
26.56 %
EPS Growth in Last Year:
15.71 %
Sales Growth in Last Quarter:
6.74 %
Sales Growth in Last Quarter:
-0.29 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##